If you have advanced renal cell carcinoma (kidney cancer), your healthcare provider may prescribe a drug called Inlyta® (axitinib). This medication is specifically approved for use in adults who have tried at least one other kidney cancer medication without success.
Clinical studies on Inlyta have shown that this drug can slow down the growth and progression of kidney cancer in some people. However, this medication is not appropriate for everyone. Before taking Inlyta, make sure your healthcare provider knows your complete medical history, including any other medications you are taking and any other medical problems you may have.
This drug comes in the form of a tablet and is taken twice daily, with 12 hours between doses. Side effects can include diarrhea, nausea, and fatigue.
(To learn more about this drug, click Inlyta. This article contains more information on what this drug is used to treat, how it works, and important safety precautions.)